Results 221 to 230 of about 74,225 (263)

De‐Escalation of Neoadjuvant Treatment for HER2‐Positive Breast Cancer

International Journal of Cancer, Volume 159, Issue 10, Page 2393-2402, 15 November 2026.
ABSTRACT With improved prognosis in early HER2‐positive breast cancer, safely de‐escalating treatment is increasingly investigated to minimize overtreatment. This article focuses on neoadjuvant de‐escalation strategies for HER2‐positive breast cancer.
Yiyin Ma, Dedian Chen, Sheng Huang
wiley   +1 more source

Metastatic Triple Negative Breast Cancer: Navigating a Rapidly Evolving Therapeutic Landscape. [PDF]

Oncol Res
Browne IM, Esteban Garcia M, Okines AFC.
europepmc   +1 more source

Epigenetic Markers of Cell Division and Ageing in Relation to Breast Cancer Survival

International Journal of Cancer, Volume 159, Issue 10, Page 2452-2462, 15 November 2026.
ABSTRACT Breast cancer remains a major challenge to public health. Biomarkers may be useful to improve prediction of breast cancer survival. Several epigenetic markers of cell division and ageing based on DNA methylation have been proposed. In this study, we measured these epigenetic markers in breast tumours and assessed their prognostic value.
Luca Li, Elaheh Zarean, Danmeng Lily Li, Yiyue Zhu, Shuai Li, Enes Makalic, Catriona McLean, Graham G. Giles, Roger L. Milne, Melissa C. Southey, Pierre‐Antoine Dugué   +10 more
wiley   +1 more source

Morphology-Guided Diagnosis of Triple-Negative Breast Carcinoma: From Histopathological Evaluation to Molecular Testing. [PDF]

J Clin Med
Zuccalà V, Rizzuto I, Pepe L, Martorana TM, Fiorentino V, Tralongo P, Ricciardi G, Ciappina G, Aricò FM, Marino MA, Berretta M, Martini M, Fadda G, Tuccari G, Ieni A.   +14 more
europepmc   +1 more source

Genome Sequencing Outperforms Exome Sequencing in Formalin‐Fixed Paraffin Embedded Tumors Leading to Improved Treatment Options

Cancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Precision oncology is based on comprehensive molecular characterization of a patient's tumor. This is mostly realized by next‐generation sequencing panels or exome sequencing. Data on the value of genome sequencing from formalin‐fixed paraffin embedded (FFPE) material in a clinical setting is still scarce.
Nadja Ballin, Alexander Ott, Michaela Pogoda, Florian Harmuth, Vijay Kumar Ulaganathan, Anton Karelin, Cristiana Roggia, Irina Bonzheim, Stephan Singer, Holly Sundberg‐Malek, Pavlos Missios, Stephan Ossowski, Tobias B. Haack, Olaf Riess, Michael Bitzer, Nisar Malek, Christopher Schroeder, Sorin Armeanu‐Ebinger   +17 more
wiley   +1 more source

Correction to “Losartan Enhances Radiosensitivity by Reversing Immunosuppressive Tumor Microenvironment Induced by Radiotherapy in TNBC”

Cancer Science, EarlyView.
wiley   +1 more source

Meroterpenoids Produced by Fungi: Occurrence, Structural Diversity, and Biological Activity (An Update: February 2020 to December 2025)

Chemistry &Biodiversity, Volume 23, Issue 11, November 2026.
This review firstly summarizes the update of meroterpenoids from February 2020 to December 2025 by applying a new classification method based on twelve key non‐terpene precursors. ABSTRACT Meroterpenoids are a class of hybrid natural products, biosynthesized from terpenoid fragments and non‐terpenoid precursors, exhibiting a wide range of biological ...
Yuqian Tang, Jinqin Wei, Zhao Jiang, Yingming Luo, Yan Zhou, Jiafan Yang, Hui Cui   +6 more
wiley   +1 more source

LINC01537 Regulates Malignant Phenotypes and Predicts Prognosis in Breast Cancer, and Its Bioinformatics Analysis

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 11, November 2026.
LINC01537 is upregulated in breast cancer, predicting poor prognosis; it acts as a ceRNA sponging miR‐138‐5p to upregulate EZH2, promoting breast cancer progression via this axis. ABSTRACT Breast cancer is a highly heterogeneous malignancy and constitutes one of the leading health threats to women globally.
Yuetong Guo, Libo Shi
wiley   +1 more source